Alogliptin
Alogliptin is an oral anti-diabetic medication belonging to the dipeptidyl peptidase-4 (DPP-4) inhibitor class. It works by increasing the levels of active incretin hormones, which stimulate insulin release in response to meals and decrease glucagon secretion, thereby lowering blood glucose levels.
Dosage by Body Weight
The standard adult dose is 25 mg taken orally once daily, with or without food. Dosage adjustments are required for patients with moderate to severe renal impairment (12.5 mg once daily for moderate renal impairment, and 6.25 mg once daily for severe renal impairment or end-stage renal disease). It is not indicated for pediatric use.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric populations.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric populations.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric populations.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric populations.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric populations.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric populations. |
| 5-7 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric populations. |
| 8-10 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric populations. |
| 11-15 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric populations. |
| 16-20 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric populations. |
Formulation
Purpose
Used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
Generic Name
AlogliptinBranded Drug Names
Alogliptin is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.